SPRA Therapeutics specializes in developing innovative solutions for pain management through its advanced PNS technology.
SPR Therapeutics has raised $60.0M in total funding. The most recent round was Debt Financing. The last funding was announced in February 2024.
SPR Therapeutics's investors include Revelation Partners, RC Capital, U.S. Department of War, JumpStart Inc., Kli Capital.
SPR Therapeutics is headquartered in Cleveland, United States.
SPRA Therapeutics specializes in developing innovative solutions for pain management through its advanced PNS technology.
SPR Therapeutics is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SPR Therapeutics — Funding & Investors." VCBacked, February 1, 2024, https://www.vcbacked.co/company/spr-therapeutics. Accessed September 30, 2026.
VCBacked. (2024). SPR Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/spr-therapeutics
{{cite web |title=SPR Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/spr-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated